Clinical Trial Update: Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodine [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating 2% povidone-iodine for epidemic keratoconjunctivitis has completed. The study addresses treatment of viral conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidemic Keratoconjunctivitis

Drugs mentioned

• povidone-iodine 2% ophthalmic solution (povidone-iodine)

Snippet

Sponsor: Mahidol University | Conditions: Viral Conjunctivitis | Phase 4 | Status: COMPLETED